@KidsCancerInst are pleased to announce that after an extensive international search, Prof, Louis Chesler has been appointed as the new Executive Director for the Institute, with effect from 1 December 2025: https://t.co/GuXZnV7nmG
A study led by researchers at @kidscancerinst has uncovered a potential new therapeutic approach for #neuroblastoma, the most common tumour in children under five: https://t.co/W0nYvrnQEU
Listen to Prof. Michelle Haber sharing her journey and the progress she's seen throughout her 42years dedicated to childhood cancer research https://t.co/c1Z8XBvSEp
While we are grateful for the Federal Government’s support for Australia’s medical research to date, more needs to be done to cover the full costs of research https://t.co/JVHhhA9VM3 #StandUpForScience2025
We're delighted Prof Michelle Haber AM, has received the prestigious Lemberg Medal. Awarded by ASBMB, the medal recognises distinguished scientists who have demonstrated excellence in biochemistry & molecular biology & made significant contributions to the scientific community.
Leading childhood cancer researcher, Professor Maria Kavallaris AM @MK_CCI, has been inducted into the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.
https://t.co/loztPhtMOx
Australian-led study investigating deadly brain cancers mainly affecting children sheds new light on what drives development of these cancers and how they may be treated, providing fresh hope to families of children diagnosed: https://t.co/4WT7uy7pyS @ProfDavidZieg @DrMMateos
@KidsCancerInst Computational Biology Group has recently published three important pieces of research in high-impact international journals, offering valuable new insights and tools to help identify and understand splice-altering variants.
https://t.co/8ts0DQLYJa
Our passionate and dedicated Philanthropy Team are responsible for engaging donors and securing financial support, and YOU could play a role in this incredible mission.
Now hiring: Relationship Manager
https://t.co/4sfSyJceWK
Prof. Richard Lock featured in HemaSphere podcast discussing his internationally recognised program using PDX models in preclinical testing, to study leukaemia biology and test new treatments in a highly personalised way.
https://t.co/oT01V71mp7
Great to be able to share our latest manuscript - results of many many years of work from our lab and collaborators: High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic. See 🧵for details: https://t.co/QXAjL9AEdK
Our passionate and dedicated Philanthropy Team is expanding and we have two new roles available for the right candidates.
Relationship Manager - Gift in Wills
https://t.co/uiNbBKiDaH
Trusts & Foundations Lead
https://t.co/zRurQP2Ry6
@coopsfoundation We're so grateful to Cooper for the legacy he has left behind and the incredible contribution his family has made to sarcoma research in his honour 💚
We're challenging YOU to conquer 86km this March for the 86 children diagnosed with cancer every month in Australia.
Walk, run, skip or cartwheel. Do a little each day, or a lot. However you choose to tackle the 86km is up to you.
Register now https://t.co/xFjuZSJtsR
We are proud to say that 84c of every dollar donated to @kidscancerinst is spent directly on research and scientific activity to help cure #childhoodcancer. With the brightest brains, cutting-edge facilities, the greatest determination, and with your support #ItsNotIfItsWhen
Whether you want to make a one-time donation, become a regular giver, leave a gift in your will, host a fundraising event, or become a corporate partner - your donations will fund research that will save young lives.
https://t.co/vpoWUmvluU
Did you know that almost all cancer treatments used in children today were actually developed for adults? We need dedicated research to understand, treat and ultimately find a cure for ALL children with cancer. And that's exactly what we're doing right now in our labs!